FindTrial
Sign In

Treatment of Chromoblastomycosis with ALA-PDT

Treatment of Chromoblastomycosis with ALA-PDT

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900023978
Enrollment
Unknown
Registered
2019-06-20
Start date
2012-01-01
Completion date
Unknown
Last updated
2019-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chromoblastomycosis

Interventions

Case series:ALA-PDT therapy

Sponsors

The 3rd Affiliated Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patient diagnosed with chromoblastomycosis

Exclusion criteria

Exclusion criteria: 1. Light sensitive persons; 2. Pregnant women/lactating patients

Design outcomes

Primary

MeasureTime frame
Skin lesions improved;Mycological detection;—

Countries

China

Contacts

Public ContactYongxuan Hu

The 3rd Affiliated Hospital of Southern Medical University

huyongxuan2003@163.com+86 13798082552

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026